Clinical Trial Update: Lacosamide IV and EEG/EKG (LIVE) Study [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating intravenous lacosamide with EEG/EKG monitoring was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Epilepsy

Drugs mentioned

• Lacosamide IV (lacosamide)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Focal Epilepsy | Phase 2 | Status: TERMINATED